Phase 1-2 Vatalanib and Gemcitabine in Advanced Pancreatic Cancer

Clinical trial NCT00185588 · COMPLETED

Trial details

NCT number: NCT00185588
Sponsor: George Albert Fisher
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2004-10-01
Primary completion: 2009-01-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.